Advancements in Heart Disease Treatment Highlighted

In Bangladesh, cardiovascular disease treatment is heavily centralized in Dhaka, leading to long wait times and high costs for patients. Government hospitals struggle under a patient load that often exceeds capacity, forcing many to seek expensive private care. Meanwhile, advancements in cardiology, particularly in gene and cell therapies, offer new hope for treating heart diseases in the U.S. and EU, as highlighted by ongoing clinical trials such as Rocket Pharmaceuticals' RP-A501 for Danon disease. Innovations in structural heart disease management are also making strides, with improved diagnostic techniques and minimally invasive procedures enhancing patient outcomes. Globally, cardiovascular diseases remain the leading cause of death, prompting continuous development in interventional cardiology methods. Wearable technologies for monitoring heart health represent a significant leap from historical methods, showcasing the evolution of cardiological care.